7799 — Heron Neutron Medical Cashflow Statement
0.000.00%
- TWD98.74bn
- TWD98.17bn
Annual cashflow statement for Heron Neutron Medical, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS |
Status: | Final | Final | Final |
Net Income/Starting Line | -86.2 | -126 | -260 |
Depreciation | |||
Amortisation | |||
Non-Cash Items | -1.14 | -0.054 | 24.1 |
Unusual Items | |||
Other Non-Cash Items | |||
Changes in Working Capital | 11.3 | 56.5 | -44.5 |
Change in Accounts Receivable | |||
Change in Inventories | |||
Change in Prepaid Expenses | |||
Change in Other Assets | |||
Change in Accounts Payable | |||
Change in Other Liabilities | |||
Other Operating Cash Flow | |||
Cash from Operating Activities | -62 | -54.6 | -260 |
Capital Expenditures | -114 | -56.2 | -49 |
Purchase of Fixed Assets | |||
Purchase / Acquisition of Intangibles | |||
Other Investing Cash Flow Items | 0.326 | 0 | -100 |
Sale of Fixed Assets | |||
Purchase of Investments | |||
Other Investing Cash Flow | |||
Cash from Investing Activities | -114 | -56.2 | -149 |
Net Issuance / Retirement of Stock | |||
Net Issuance / Retirement of Debt | |||
Cash from Financing Activities | 178 | 336 | 900 |
Beginning Cash Balance | |||
Ending Cash Balance | |||
Net Change in Cash | 2.77 | 225 | 491 |